港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

康諾亞-B

42.650

+1.0002.40%

成交量：133.45萬

成交額：5,697.14萬

市值：119.31億

市盈率：-20.39

高：43.500

開：39.850

低：39.850

收：41.650

資料載入中...

總覽公司新聞公告

康諾亞-B早盤漲逾3% CM310獲批進度超預期

港股異動 | 康諾亞-B(02162)現漲超3% CM310獲批進度超預期價格下降後有望快速提升滲透率

2024藥企出海：做難而正確的事

国际金融报

康諾亞-B(2162.HK)：獲批進度超預期 2025 年商業化可期

南向資金12月27日持有康諾亞-B市值24.14億港元，持股比例佔29.1%

以生物醫藥為匙打開全球最大“隱形市場”——四川服務貿易成果加速上“新”

每日经济新闻

康諾亞-B12月27日主力資金流出1088萬元連續3日減倉

康諾亞-B盤中異動股價大跌5.04%報30.150港元

康諾亞(02162.HK)“康悦達”慢性鼻竇炎伴鼻息肉適應症開出全國首張處方

阿斯达克财经

浙商證券首予康諾亞-B(02162)“買入”評級，目標價最高看至65.55港元

開源證券：血液瘤各亞型均有孵化“重磅炸彈”藥物潛力關注創新藥企

康諾亞-B：深耕自免&腫瘤 IL-4R商業化領先

兩款帕妥珠單抗生物類似藥獲批上市康諾亞司普奇拜單抗第二項適應症獲批丨醫藥早參

每日经济新闻

康諾亞司普奇拜單抗獲批新適應症上市

康諾亞(02162.HK)治療慢性鼻竇炎伴鼻息肉藥物新適應症上市申請獲批

阿斯达克财经

康諾亞-B(02162)：國家藥監局批准司普奇拜單抗用於治療慢性鼻竇炎伴鼻息肉的新適應症上市申請

康諾亞-B(2162.HK)：商業化篤定前行管線出海大有可為

港股異動 | 康諾亞-B(02162)一度跌超10% 股價暫現七連陰傳公司競品醫保續約降價超預期

康諾亞-B盤中異動早盤快速下挫5.02%

康諾亞-B(02162)下跌5.02%，報31.25元/股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02162/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02162","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02162\",,,,,undefined,":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康諾亞-B","latestPrice":42.65,"timestamp":1744877289031,"preClose":41.65,"halted":0,"volume":1334500,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-2.0913301347442297,"marketStatus":"休市中","change":1,"latestTime":"04-17 16:08:09","open":39.85,"high":43.5,"low":39.85,"amount":56971362,"amplitude":0.087635,"askPrice":42.65,"askSize":1500,"bidPrice":42.6,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-2.0913301347442297,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1625673600000,"exchange":"SEHK","adjPreClose":41.65,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.6674368823170371,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02162\",,,,,undefined,":{"symbol":"02162","floatShares":279735566,"roa":"-10.23%","roe":"-18.85%","lyrEps":-2.09133,"volumeRatio":0.6674368823170371,"shares":279735566,"dividePrice":0,"high":43.5,"amplitude":0.087635,"preClose":41.65,"low":39.85,"week52Low":26.6,"pbRate":"4.53","psRate":"26.21","week52High":49.6,"institutionHeld":0,"latestPrice":42.65,"committee":0.538462,"eps":-2.0913301347442297,"divideRate":0,"volume":1334500,"delay":0,"ttmEps":-2.0913301347442297,"open":39.85,"prevYearClose":30.9,"prevWeekClose":43.85,"prevMonthClose":44.4,"prevQuarterClose":44.4,"fiveDayClose":40.8,"twentyDayClose":39.65,"sixtyDayClose":29.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02162\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495639209","title":"康諾亞-B早盤漲逾3% CM310獲批進度超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2495639209","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495639209?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 11:54","pubTimestamp":1735617240,"startTime":"0","endTime":"0","summary":"　　康诺亚-B早盘上涨2.83%，现报30.9港元，成交额4949.11万港元。　　康诺亚此前发布公告，中国国家药品监督管理局已于近日批准司普奇拜单抗治疗慢性鼻窦炎伴鼻息肉的新适应症上市申请。　　国泰君安指出，CM310成为国内首款CRSwNP生物药，获批进度超预期；未来可适应症众多，预计有望为CM310销售持续贡献增量。鼻窦炎独家适应症有望带动收入增长，25年CM310销售收入预计有望超5亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-31/doc-ineciptz2728295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02162","BK1587","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2495636917","title":"港股異動 | 康諾亞-B(02162)現漲超3% CM310獲批進度超預期 價格下降後有望快速提升滲透率","url":"https://stock-news.laohu8.com/highlight/detail?id=2495636917","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495636917?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 11:24","pubTimestamp":1735615492,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康诺亚-B现涨超3%，截至发稿，涨2.83%，报30.9港元，成交额4128.9万港元。国泰君安指出，CM310成为国内首款CRSwNP生物药，获批进度超预期；未来可适应症众多，预计有望为CM310销售持续贡献增量。CRSwNP治疗靶点众多，但目前IL-4R疗效最优，CM310临床数据优异。参考IL-17单抗销售情况，价格下降后渗透率有望快速提升，预计销量有望快速增加。鼻窦炎独家适应症有望带动收入增长，25年CM310销售收入预计有望超5亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1231464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02162","BK1574","BK1583","BK1587","BK1161"],"gpt_icon":0},{"id":"2495054976","title":"2024藥企出海：做難而正確的事","url":"https://stock-news.laohu8.com/highlight/detail?id=2495054976","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495054976?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 20:41","pubTimestamp":1735562466,"startTime":"0","endTime":"0","summary":"2024年，出海依然是生物医药产业的关键词。ADC、双抗药物合作交易火爆，出海数量再创新高；交易金额上限不断突破，多家药企凭借出海扭亏为盈。海外市场为生物医药产业带来了新的增量和发展方向，但走好出海之路绝非易事。近年来，创新药海外合作数量上升的同时，也有部分合作半路终止。此外，还有企业受地缘政治等因素影响，割舍或是调整海外业务。不过，好在各方都没有放弃，而是积极探索出新的道路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412303282962268.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282962268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02162","BK4588","BMS","BK4231","GSK.UK","ADC","PML","BK4007","BK1574","NDAA","BK4080","GSK","BK1161","BK4532","09939","BK1583","BK1515","BK1587","BK4585","LU1829250122.USD"],"gpt_icon":0},{"id":"2495447155","title":"康諾亞-B(2162.HK)：獲批進度超預期 2025 年商業化可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2495447155","media":"国泰君安","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495447155?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 00:00","pubTimestamp":1735488000,"startTime":"0","endTime":"0","summary":"本报告导读：CM310 近日获批CRSwNP 适应症，获批进度超预期，鼻窦炎独家适应症有望带动收入增长，2025 年CM310 销售收入有望超5 亿元。CM310 成为国内首款CRSwNP 生物药，获批进度超预期。CM310的慢性鼻窦炎伴鼻息肉适应症于2024.06 递交NDA 并被纳入优先审评审批，2024.12.17 获批上市，获批速度超预期，成为目前国内首款获批用于治疗CRSwNP 的生物制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230210726a20f16fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230210726a20f16fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1161","BK1574","BK1583","BK1587"],"gpt_icon":0},{"id":"2494351718","title":"南向資金12月27日持有康諾亞-B市值24.14億港元，持股比例佔29.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494351718","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494351718?lang=zh_tw&edition=fundamental","pubTime":"2024-12-28 07:09","pubTimestamp":1735340977,"startTime":"0","endTime":"0","summary":"12月28日，Choice数据显示，南向资金截至12月27日持有康诺亚-B8141.84万股，持股市值24.14亿港元，较上个交易日减少1.66亿港元，持股数量占发行股的29.1%。截至27日收盘，康诺亚-B当日下跌6.61%，收盘价报29.65港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/28070946909686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02162","BK1587","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2494775148","title":"以生物醫藥為匙打開全球最大“隱形市場”——四川服務貿易成果加速上“新”","url":"https://stock-news.laohu8.com/highlight/detail?id=2494775148","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494775148?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 17:39","pubTimestamp":1735292374,"startTime":"0","endTime":"0","summary":"近年来，四川省生物医药产业诞生的知识产权国际授权交易不断刷新创新药License-out（许可输出,即中国创新药对外授权许可）的金额新高。统计数据显示，2023年四川省医药健康产业实现营业收入近6000亿元，而仅以科伦博泰、百利天恒等五家医药企业的知识产权国际授权交易计算，其潜在交易总额就超200亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412273281346529.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412273281346529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4532","LU1829250122.USD","BK4007","02162","PML","GSK","BMS","GSK.UK","BK4585","BK1587","BK1161","BK1583","BK4588","BK1574"],"gpt_icon":0},{"id":"2494879889","title":"康諾亞-B12月27日主力資金流出1088萬元 連續3日減倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2494879889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494879889?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 16:16","pubTimestamp":1735287408,"startTime":"0","endTime":"0","summary":"12月27日, 康诺亚-B股价跌6.61%，报收29.65元，成交金额1.65亿元，换手率1.97%，振幅8.82%，量比1.60。康诺亚-B今日主力资金净流出1088万元，连续3日净流出，上一交易日主力净流出699万元，今日环比增加55.65%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为63.64%，平均跌幅为2.65%。该股近5个交易日下跌12.18%，主力资金累计净流出2323万元；近20日主力资金累计净流出2876万元，其中净流出天数为8日。该股主力净额占比0.13%，港股市场排名2631/2656。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227161717ab94811c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227161717ab94811c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02162","BK1574","BK1583","BK1587"],"gpt_icon":0},{"id":"2494825095","title":"康諾亞-B盤中異動 股價大跌5.04%報30.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494825095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494825095?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 13:08","pubTimestamp":1735276117,"startTime":"0","endTime":"0","summary":"2024年12月27日下午盘13时08分，康诺亚-B股票出现异动，股价快速下跌5.04%。截至发稿，该股报30.150港元/股，成交量177.95万股，换手率0.64%，振幅5.20%。资金方面，该股资金流入1230.6万港元，流出3314.95万港元。康诺亚-B股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，和铂医药-B、华康生物医学、康宁杰瑞制药-B涨幅较大，振幅较大的相关个股有和铂医药-B、康宁杰瑞制药-B、思路迪医药股份，振幅分别为27.27%、15.70%、10.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122713083795eebec6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122713083795eebec6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1583","02162","BK1574"],"gpt_icon":0},{"id":"2494978828","title":"康諾亞(02162.HK)“康悦達”慢性鼻竇炎伴鼻息肉適應症開出全國首張處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2494978828","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494978828?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 12:14","pubTimestamp":1735272840,"startTime":"0","endTime":"0","summary":"康诺亚(02162.HK) 公布，旗下司普奇拜单抗注射液“康悦达”于周三(25日)在首都医科大学附属北京同仁医院开出全国首张处方。康悦达为国内首个、全球唯二获批上市的IL-4Rα抗体药物，于本月中获国家药品监督管理局批准上市，用于治疗慢性鼻窦炎伴鼻息肉适应症。另外，该药用于治疗季节性过敏性鼻炎的药品上市许可申请亦已获受理。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-24 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220419164246914_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220419164246914_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1406445/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","02162","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2494451948","title":"浙商證券首予康諾亞-B(02162)“買入”評級 ，目標價最高看至65.55港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494451948","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494451948?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 09:26","pubTimestamp":1735262812,"startTime":"0","endTime":"0","summary":"该行预测，根据DCF估值模型，计算公司CM310合理估值预计91.61亿元及CMG901国内销售+海外授权及分成收入现值69.22亿元，合计估值预计为160.83亿元人民币，敏感性测试结果显示合理市值区间为151-172亿元人民币。对应0.9371汇率下换算得到市值161-183亿港币，对应目标价为57.69-65.55港币/股，首次覆盖并给予“买入”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/M2ZiNmJjNGMwZDk5N2EzMzdhMmQ3YTNjNTY2NTQwOTU0NTAzNDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/M2ZiNmJjNGMwZDk5N2EzMzdhMmQ3YTNjNTY2NTQwOTU0NTAzNDA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1950287","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","601878"],"gpt_icon":0},{"id":"2494188827","title":"開源證券：血液瘤各亞型均有孵化“重磅炸彈”藥物潛力 關注創新藥企","url":"https://stock-news.laohu8.com/highlight/detail?id=2494188827","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494188827?lang=zh_tw&edition=fundamental","pubTime":"2024-12-26 10:48","pubTimestamp":1735181328,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，开源证券发布研报称，血液瘤亚型较多，各细分亚型仍存在较大未满足的临床需求，蕴含着较大的市场机会，靶向疗法与免疫疗法有望为治疗带来新曙光。同时，包括慢性白血病、惰性淋巴瘤等在内的血液瘤亚型侵袭性较低、治疗周期较长，一般需要长期用药，患者粘性相对较高，有诞生“重磅炸弹”药物的潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1229530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","BK1574","BK1583","BK1587","06855","02162","06978","BK1161","159992"],"gpt_icon":0},{"id":"2494881211","title":"康諾亞-B：深耕自免&腫瘤 IL-4R商業化領先","url":"https://stock-news.laohu8.com/highlight/detail?id=2494881211","media":"浙商证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494881211?lang=zh_tw&edition=fundamental","pubTime":"2024-12-26 00:00","pubTimestamp":1735142400,"startTime":"0","endTime":"0","summary":"投资要点公司是一家深耕自免及肿瘤领域的创新药企业，在IL-4Rα、CLDN18.2、CD3等多个领域布局了高潜力管线，其中，核心产品CM310 是国产首家获批的IL-4Rα 抗体药物，已进入商业化阶段。自免管线涵盖IL-4Rα、TSLP 及CD38 等热门靶点，整体进度领先。CM310：国产首款获批IL-4Rα 抗体，多适应症领先潜力大市场潜力大，多个重磅适应症临床中后期，奠定持续放量基础。从赛诺菲IL-4Rα 药物达必妥2023 年全球销售额突破百亿美元大关看，相关靶点药物市场空间足够大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226125631ab92e7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226125631ab92e7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1583","BK1161","02162","BK1574"],"gpt_icon":0},{"id":"2493710070","title":"兩款帕妥珠單抗生物類似藥獲批上市  康諾亞司普奇拜單抗第二項適應症獲批丨醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2493710070","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493710070?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 07:54","pubTimestamp":1734998060,"startTime":"0","endTime":"0","summary":"帕妥珠单抗原研是由罗氏研发的，2012年首次获FDA批准上市，2018年首次在中国获批上市。目前已在全球获批多项适应症。但目前国内共有7家企业开发帕妥珠单抗类似药，后续竞争可能加剧。NO.2 康诺亚司普奇拜单抗第二项适应症获批12月23日，康诺亚宣布公司自主研发的1类新药康悦达获得国家药品监督管理局批准上市，用于治疗慢性鼻窦炎伴鼻息肉。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224075611ab8f2e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224075611ab8f2e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1574","BK1587","BK1583","BK1161","02162"],"gpt_icon":0},{"id":"2493731388","title":"康諾亞司普奇拜單抗獲批新適應症上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2493731388","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493731388?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 17:23","pubTimestamp":1734945828,"startTime":"0","endTime":"0","summary":"财中社12月23日电康诺亚-B（02162）发布自愿性公告，宣布中国国家药品监督管理局已批准司普奇拜单抗（商品名：康悦达）用于治疗慢性鼻窦炎伴鼻息肉的新适应症上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412233276334082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02162","BK1583","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2493873568","title":"康諾亞(02162.HK)治療慢性鼻竇炎伴鼻息肉藥物新適應症上市申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2493873568","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493873568?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 16:43","pubTimestamp":1734943380,"startTime":"0","endTime":"0","summary":"康诺亚(02162.HK) 公布，国家药监局已于近日批准司普奇拜单抗(抗IL-4Rα单克隆抗体，商品名：康悦达，研发代号：CM310)治疗慢性鼻窦炎伴鼻息肉的新适应症上市申请(sNDA)。本次获批是基于一项多中心、随机、双盲、安慰剂对照的III期临床研究，主要用于确证司普奇拜单抗注射液在治疗慢性鼻窦炎伴鼻息肉患者中的有效性及安全性。研究结果显示该项III期临床试验数据结果积极。(jl/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-23 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220419164250683_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220419164250683_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405968/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02162","BK1574","BK1161","BK1587","BK1583"],"gpt_icon":0},{"id":"2493891733","title":"康諾亞-B(02162)：國家藥監局批准司普奇拜單抗用於治療慢性鼻竇炎伴鼻息肉的新適應症上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2493891733","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493891733?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 16:32","pubTimestamp":1734942756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康诺亚-B 发布公告，中国国家药品监督管理局已于近日批准司普奇拜单抗治疗慢性鼻窦炎伴鼻息肉的新适应症上市申请。本次获批是基于一项多中心、随机、双盲、安慰剂对照的III期临床研究，主要用于确证司普奇拜单抗注射液在治疗慢性鼻窦炎伴鼻息肉患者中的有效性及安全性。同时有效减轻鼻窦炎症、恢复嗅觉、改善鼻部综合症状，并提高生活质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康诺亚-B(02162)：国家药监局批准司普奇拜单抗用于治疗慢性鼻窦炎伴鼻息肉的新适应症上市申请","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1161","BK1574","02162","BK1583"],"gpt_icon":0},{"id":"2493756476","title":"康諾亞-B(2162.HK)：商業化篤定前行 管線出海大有可為","url":"https://stock-news.laohu8.com/highlight/detail?id=2493756476","media":"华泰证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493756476?lang=zh_tw&edition=fundamental","pubTime":"2024-12-23 00:00","pubTimestamp":1734883200,"startTime":"0","endTime":"0","summary":"受竞品医保价格调整等因素影响，公司股价近期出现较大波动。催化兑现可期我们预计未来12 个月内公司将迎多项催化：1）司普奇拜单抗治疗过敏性鼻炎有望在未来1 年内获批；2）公司有望于1H25 启动CM313 治疗SLE、ITP、IgAN 的II 期临床；3）已达成出海授权的CM512 及CM336 有望于2025 年启动海外I/II 期临床。维持“买入”评级。风险提示：1）药物未在临床中取得预期积极结果；2）药物商业化不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223200140a204b9de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223200140a204b9de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1583","02162","BK1574"],"gpt_icon":0},{"id":"2492567984","title":"港股異動 | 康諾亞-B(02162)一度跌超10% 股價暫現七連陰 傳公司競品醫保續約降價超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2492567984","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492567984?lang=zh_tw&edition=fundamental","pubTime":"2024-12-20 10:36","pubTimestamp":1734662176,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康诺亚-B跌超10%，股价暂现七连阴。消息面上，近日市场流传有关达必妥医保续约降价超预期的消息。值得注意的是，度普利尤单抗自从上市以来价格总体呈现下降趋势。2020年7月在国内刚上市时，度普利尤单抗规格为300mg/支，每支价格高达6666元；2021年3月被纳入医保目录后，该药同规格价格降为每支3160元；去年1月医保续约时，该药同规格价格进一步降至2780元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1583","BK1161","02162","BK1574"],"gpt_icon":0},{"id":"2492455888","title":"康諾亞-B盤中異動 早盤快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492455888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492455888?lang=zh_tw&edition=fundamental","pubTime":"2024-12-20 09:59","pubTimestamp":1734659987,"startTime":"0","endTime":"0","summary":"2024年12月20日早盘09时59分，康诺亚-B股票出现波动，股价大幅下挫5.02%。截至发稿，该股报31.250港元/股，成交量75.45万股，换手率0.27%，振幅5.02%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康诺亚-B股票所在的生物技术行业中，整体跌幅为0.08%。康诺亚-B公司简介：康诺亚生物医药科技有限公司是一家生物科技公司,专注于自主发现及开发自体免疫及肿瘤治疗领域的创新生物疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095948a1fc7773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095948a1fc7773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1583","BK1161","BK1587","BK1574"],"gpt_icon":0},{"id":"2492455818","title":"康諾亞-B(02162)下跌5.02%，報31.25元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492455818","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492455818?lang=zh_tw&edition=fundamental","pubTime":"2024-12-20 09:59","pubTimestamp":1734659986,"startTime":"0","endTime":"0","summary":"12月20日，康诺亚-B(02162)盘中下跌5.02%，截至09:59，报31.25元/股，成交2409.87万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法，主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项，其中9项已进入不同阶段临床研发，多项位于中国第一，世界前三，包含一项世界首创ADC新药，两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报，康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/20095946620697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK1587","BK1583","BK1161","02162"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":189,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02162\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02162","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-27","symbol":"02162","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724722200000,"name":null,"time":"盤後","dateTimestamp":1724688000000,"actualEps":null},{"date":"2024-03-26","symbol":"02162","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-24","symbol":"02162","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692840600000,"name":null,"time":"","dateTimestamp":1692806400000,"actualEps":null},{"date":"2023-03-17","symbol":"02162","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679016600000,"name":null,"time":"","dateTimestamp":1678982400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02162\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02162\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1743436800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02162\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02162","date":"2025-04-17","current":-21.449842,"percent":0.531618,"low":-75.021907,"twenty":-47.728144,"median":-22.667693,"eighty":-2.112547,"high":-0.918807,"avg":-25.266768,"sd":19.861801,"marketCap":11754321489},"quantilePoints":[{"date":"2021-07-09","current":-19.162927,"twenty":-18.949964,"median":-16.76249,"eighty":-14.711698,"marketCap":18807126980},{"date":"2021-07-16","current":-18.776742,"twenty":-19.237066,"median":-18.807989,"eighty":-17.152246,"marketCap":18427732488},{"date":"2021-07-23","current":-17.618697,"twenty":-19.184823,"median":-18.776246,"eighty":-18.022613,"marketCap":17289549010},{"date":"2021-07-30","current":-17.657215,"twenty":-19.136205,"median":-18.698458,"eighty":-16.553895,"marketCap":17385565426},{"date":"2021-08-06","current":-18.597059,"twenty":-19.136205,"median":-18.68783,"eighty":-17.309281,"marketCap":18266732459},{"date":"2021-08-13","current":-17.775416,"twenty":-19.159423,"median":-18.698458,"eighty":-17.567372,"marketCap":17483472875},{"date":"2021-08-20","current":-15.116391,"twenty":-19.133869,"median":-18.605125,"eighty":-17.508281,"marketCap":14825984998},{"date":"2021-08-27","current":-14.325953,"twenty":-19.029178,"median":-18.069277,"eighty":-15.500902,"marketCap":14112659304},{"date":"2021-09-03","current":-2.665037,"twenty":-18.872675,"median":-17.808518,"eighty":-14.711698,"marketCap":14154619639},{"date":"2021-09-10","current":-2.889349,"twenty":-18.789241,"median":-17.637409,"eighty":-13.902099,"marketCap":15385456130},{"date":"2021-09-17","current":-2.734582,"twenty":-18.776146,"median":-17.505299,"eighty":-2.874329,"marketCap":14518275875},{"date":"2021-09-24","current":-2.75965,"twenty":-18.761327,"median":-16.432963,"eighty":-2.778159,"marketCap":14658143658},{"date":"2021-09-30","current":-2.700581,"twenty":-18.731857,"median":-15.436816,"eighty":-2.745012,"marketCap":14392394870},{"date":"2021-10-08","current":-2.561601,"twenty":-18.700103,"median":-14.765165,"eighty":-2.70068,"marketCap":13651095620},{"date":"2021-10-15","current":-2.334285,"twenty":-18.698458,"median":-14.703758,"eighty":-2.689311,"marketCap":12448232687},{"date":"2021-10-22","current":-2.143171,"twenty":-18.677203,"median":-14.267689,"eighty":-2.634146,"marketCap":11511118540},{"date":"2021-10-29","current":-2.088441,"twenty":-18.61319,"median":-3.090995,"eighty":-2.598807,"marketCap":11189422640},{"date":"2021-11-05","current":-2.025061,"twenty":-18.597059,"median":-2.870574,"eighty":-2.541082,"marketCap":10867726739},{"date":"2021-11-12","current":-1.910328,"twenty":-18.29189,"median":-2.805921,"eighty":-2.289961,"marketCap":10294268828},{"date":"2021-11-19","current":-2.26913,"twenty":-18.069277,"median":-2.754866,"eighty":-2.242018,"marketCap":12210457455},{"date":"2021-11-26","current":-2.611393,"twenty":-17.907229,"median":-2.734582,"eighty":-2.238418,"marketCap":14056712191},{"date":"2021-12-03","current":-2.53136,"twenty":-17.841621,"median":-2.70083,"eighty":-2.242018,"marketCap":13651095620},{"date":"2021-12-10","current":-2.234466,"twenty":-17.775416,"median":-2.693016,"eighty":-2.242018,"marketCap":12070589672},{"date":"2021-12-17","current":-1.969142,"twenty":-17.657215,"median":-2.681903,"eighty":-2.198856,"marketCap":10629951508},{"date":"2021-12-24","current":-1.801599,"twenty":-17.637409,"median":-2.665037,"eighty":-2.113389,"marketCap":9734797696},{"date":"2021-12-31","current":-1.782191,"twenty":-17.622439,"median":-2.625661,"eighty":-2.0876,"marketCap":9650877027},{"date":"2022-01-07","current":-1.534896,"twenty":-1.704098,"median":-1.627879,"eighty":-1.527695,"marketCap":8280172753},{"date":"2022-01-14","current":-1.453948,"twenty":-1.669883,"median":-1.556361,"eighty":-1.51183,"marketCap":7860569404},{"date":"2022-01-21","current":-1.391259,"twenty":-1.63569,"median":-1.534896,"eighty":-1.46926,"marketCap":7538873503},{"date":"2022-01-28","current":-1.304246,"twenty":-1.623821,"median":-1.510565,"eighty":-1.374247,"marketCap":7049336263},{"date":"2022-02-04","current":-1.364435,"twenty":-1.621116,"median":-1.501786,"eighty":-1.358567,"marketCap":7371032164},{"date":"2022-02-11","current":-1.377188,"twenty":-1.560501,"median":-1.453948,"eighty":-1.36091,"marketCap":7454952833},{"date":"2022-02-18","current":-1.517016,"twenty":-1.552222,"median":-1.451036,"eighty":-1.364435,"marketCap":8252199197},{"date":"2022-02-25","current":-1.400429,"twenty":-1.54809,"median":-1.441856,"eighty":-1.364435,"marketCap":7636780951},{"date":"2022-03-04","current":-1.507578,"twenty":-1.539833,"median":-1.451036,"eighty":-1.369844,"marketCap":8224225640},{"date":"2022-03-11","current":-1.389171,"twenty":-1.534896,"median":-1.445096,"eighty":-1.369844,"marketCap":7566847060},{"date":"2022-03-18","current":-0.979665,"twenty":-1.532907,"median":-1.435643,"eighty":-1.358567,"marketCap":5314975754},{"date":"2022-03-25","current":-0.982717,"twenty":-1.528918,"median":-1.429599,"eighty":-1.332001,"marketCap":5331759887},{"date":"2022-04-01","current":-1.3179,"twenty":-1.517016,"median":-1.397825,"eighty":-1.261154,"marketCap":6308037013},{"date":"2022-04-08","current":-1.477979,"twenty":-1.516918,"median":-1.419667,"eighty":-1.295628,"marketCap":7077309819},{"date":"2022-04-14","current":-1.480428,"twenty":-1.512775,"median":-1.420186,"eighty":-1.312438,"marketCap":7077309819},{"date":"2022-04-22","current":-1.392349,"twenty":-1.509049,"median":-1.415098,"eighty":-1.309996,"marketCap":6531825466},{"date":"2022-04-29","current":-1.31153,"twenty":-1.506241,"median":-1.395221,"eighty":-1.308764,"marketCap":6461891574},{"date":"2022-05-06","current":-1.205149,"twenty":-1.503255,"median":-1.392349,"eighty":-1.271328,"marketCap":5888433664},{"date":"2022-05-13","current":-1.186298,"twenty":-1.499337,"median":-1.389171,"eighty":-1.220758,"marketCap":5692618768},{"date":"2022-05-20","current":-1.31073,"twenty":-1.49254,"median":-1.384218,"eighty":-1.235206,"marketCap":6377970904},{"date":"2022-05-27","current":-1.311868,"twenty":-1.481525,"median":-1.369844,"eighty":-1.235206,"marketCap":6377970904},{"date":"2022-06-02","current":-1.38785,"twenty":-1.480647,"median":-1.369844,"eighty":-1.235548,"marketCap":6783587475},{"date":"2022-06-10","current":-1.731429,"twenty":-1.500317,"median":-1.384022,"eighty":-1.237922,"marketCap":8406053758},{"date":"2022-06-17","current":-1.695836,"twenty":-1.516918,"median":-1.384891,"eighty":-1.242218,"marketCap":8224225640},{"date":"2022-06-24","current":-2.010847,"twenty":-1.534951,"median":-1.390215,"eighty":-1.257553,"marketCap":9790744810},{"date":"2022-06-30","current":-1.899212,"twenty":-1.549743,"median":-1.393274,"eighty":-1.262321,"marketCap":9231273678},{"date":"2022-07-08","current":-1.880011,"twenty":-1.623821,"median":-1.400429,"eighty":-1.269129,"marketCap":9147353008},{"date":"2022-07-15","current":-1.851172,"twenty":-1.698941,"median":-1.419667,"eighty":-1.291807,"marketCap":8923564555},{"date":"2022-07-22","current":-1.855758,"twenty":-1.725957,"median":-1.429599,"eighty":-1.304535,"marketCap":8951538112},{"date":"2022-07-29","current":-1.766614,"twenty":-1.744535,"median":-1.433618,"eighty":-1.306043,"marketCap":8531934763},{"date":"2022-08-05","current":-1.817581,"twenty":-1.744535,"median":-1.441856,"eighty":-1.30743,"marketCap":8755723215},{"date":"2022-08-12","current":-1.8644,"twenty":-1.770378,"median":-1.451036,"eighty":-1.309546,"marketCap":8993498446},{"date":"2022-08-19","current":-1.851032,"twenty":-1.788753,"median":-1.464163,"eighty":-1.31121,"marketCap":8839643885},{"date":"2022-08-26","current":-2.102,"twenty":-1.805605,"median":-1.478724,"eighty":-1.311733,"marketCap":9958586149},{"date":"2022-09-02","current":-34.599164,"twenty":-1.828013,"median":-1.480428,"eighty":-1.315487,"marketCap":9972572927},{"date":"2022-09-09","current":-36.0466,"twenty":-1.851951,"median":-1.495938,"eighty":-1.318745,"marketCap":10350215942},{"date":"2022-09-16","current":-37.90693,"twenty":-1.859627,"median":-1.505907,"eighty":-1.321265,"marketCap":10783806069},{"date":"2022-09-23","current":-33.886683,"twenty":-1.87468,"median":-1.516894,"eighty":-1.325171,"marketCap":9455062130},{"date":"2022-09-30","current":-35.623246,"twenty":-1.900823,"median":-1.530912,"eighty":-1.328777,"marketCap":9958586149},{"date":"2022-10-07","current":-36.67604,"twenty":-1.924198,"median":-1.535033,"eighty":-1.334346,"marketCap":10252308493},{"date":"2022-10-14","current":-37.625514,"twenty":-1.970352,"median":-1.54809,"eighty":-1.344356,"marketCap":10406163055},{"date":"2022-10-21","current":-38.597844,"twenty":-2.014364,"median":-1.585508,"eighty":-1.346932,"marketCap":10601977951},{"date":"2022-10-28","current":-45.703167,"twenty":-33.862283,"median":-1.627879,"eighty":-1.347563,"marketCap":12532153356},{"date":"2022-11-04","current":-47.889579,"twenty":-34.244719,"median":-1.690075,"eighty":-1.349418,"marketCap":13259465828},{"date":"2022-11-11","current":-54.075845,"twenty":-34.994866,"median":-1.704847,"eighty":-1.350052,"marketCap":15105720564},{"date":"2022-11-18","current":-54.261734,"twenty":-35.196512,"median":-1.718951,"eighty":-1.350584,"marketCap":15105720564},{"date":"2022-11-25","current":-53.682782,"twenty":-35.619635,"median":-1.724238,"eighty":-1.351761,"marketCap":14825984998},{"date":"2022-12-02","current":-48.838994,"twenty":-36.03292,"median":-1.732597,"eighty":-1.35394,"marketCap":13721029512},{"date":"2022-12-09","current":-49.869326,"twenty":-36.422906,"median":-1.741392,"eighty":-1.358753,"marketCap":14140632861},{"date":"2022-12-16","current":-49.68927,"twenty":-37.110092,"median":-1.751441,"eighty":-1.359673,"marketCap":14056712191},{"date":"2022-12-23","current":-50.662334,"twenty":-37.815892,"median":-1.768923,"eighty":-1.360488,"marketCap":14336447757},{"date":"2022-12-30","current":-49.810048,"twenty":-38.311423,"median":-1.779108,"eighty":-1.360805,"marketCap":14266513866},{"date":"2023-01-06","current":-59.889287,"twenty":-40.721309,"median":-1.788803,"eighty":-1.363025,"marketCap":17329618313},{"date":"2023-01-13","current":-63.745527,"twenty":-45.866985,"median":-1.802005,"eighty":-1.36768,"marketCap":18798230035},{"date":"2023-01-20","current":-63.149098,"twenty":-47.156842,"median":-1.813375,"eighty":-1.37425,"marketCap":18462547356},{"date":"2023-01-27","current":-66.866956,"twenty":-47.387404,"median":-1.821995,"eighty":-1.377188,"marketCap":19553516063},{"date":"2023-02-03","current":-73.564914,"twenty":-48.362249,"median":-1.829186,"eighty":-1.383736,"marketCap":21623559251},{"date":"2023-02-10","current":-69.701176,"twenty":-48.844707,"median":-1.851102,"eighty":-1.384307,"marketCap":20364749204},{"date":"2023-02-17","current":-64.035674,"twenty":-49.537684,"median":-1.855758,"eighty":-1.3847,"marketCap":18532481247},{"date":"2023-02-24","current":-64.485757,"twenty":-50.027006,"median":-1.862627,"eighty":-1.384891,"marketCap":18434573799},{"date":"2023-03-03","current":-63.780925,"twenty":-50.485877,"median":-1.867346,"eighty":-1.38785,"marketCap":18350653129},{"date":"2023-03-10","current":-60.239244,"twenty":-61.173659,"median":-60.239244,"eighty":-59.240154,"marketCap":17203737309},{"date":"2023-03-17","current":-62.669341,"twenty":-47.542697,"median":-2.429029,"eighty":-1.48035,"marketCap":18070917563},{"date":"2023-03-24","current":-45.662533,"twenty":-47.984113,"median":-2.53136,"eighty":-1.481306,"marketCap":16196689271},{"date":"2023-03-31","current":-46.093483,"twenty":-47.542697,"median":-2.548374,"eighty":-1.490337,"marketCap":16224662828},{"date":"2023-04-06","current":-48.86677,"twenty":-47.716138,"median":-2.561601,"eighty":-1.495259,"marketCap":17189750530},{"date":"2023-04-14","current":-56.564392,"twenty":-48.662655,"median":-2.598807,"eighty":-1.500317,"marketCap":19917172299},{"date":"2023-04-21","current":-49.280859,"twenty":-49.129927,"median":-2.619059,"eighty":-1.504904,"marketCap":17343605092},{"date":"2023-04-28","current":-49.630581,"twenty":-49.425987,"median":-2.634146,"eighty":-1.508068,"marketCap":17336629125},{"date":"2023-05-05","current":-50.342119,"twenty":-49.440341,"median":-2.674332,"eighty":-1.510029,"marketCap":17614015191},{"date":"2023-05-12","current":-48.855125,"twenty":-49.440341,"median":-2.686457,"eighty":-1.516894,"marketCap":16976027239},{"date":"2023-05-19","current":-45.908385,"twenty":-49.440341,"median":-2.698506,"eighty":-1.517016,"marketCap":15727789942},{"date":"2023-05-25","current":-41.54518,"twenty":-49.382925,"median":-2.701078,"eighty":-1.526538,"marketCap":14174427972},{"date":"2023-06-02","current":-34.793168,"twenty":-49.298401,"median":-2.739146,"eighty":-1.532109,"marketCap":11830515714},{"date":"2023-06-09","current":-34.925134,"twenty":-49.235615,"median":-2.759506,"eighty":-1.534498,"marketCap":11858254321},{"date":"2023-06-16","current":-37.186478,"twenty":-49.201434,"median":-2.826735,"eighty":-1.535115,"marketCap":12565588789},{"date":"2023-06-23","current":-33.387247,"twenty":-49.125677,"median":-2.870574,"eighty":-1.537968,"marketCap":11220266369},{"date":"2023-06-30","current":-34.066835,"twenty":-49.004597,"median":-3.090995,"eighty":-1.544787,"marketCap":11345090099},{"date":"2023-07-07","current":-36.762281,"twenty":-48.902064,"median":-14.267689,"eighty":-1.550569,"marketCap":12218856207},{"date":"2023-07-14","current":-41.356214,"twenty":-48.859783,"median":-14.703758,"eighty":-1.557189,"marketCap":13938649816},{"date":"2023-07-21","current":-40.557094,"twenty":-48.855125,"median":-14.786695,"eighty":-1.590509,"marketCap":13605786537},{"date":"2023-07-28","current":-46.353331,"twenty":-48.848874,"median":-15.757242,"eighty":-1.616876,"marketCap":15533619696},{"date":"2023-08-04","current":-44.08654,"twenty":-48.841279,"median":-17.264004,"eighty":-1.625174,"marketCap":14798546621},{"date":"2023-08-11","current":-38.18706,"twenty":-48.770107,"median":-17.618697,"eighty":-1.639596,"marketCap":12745889732},{"date":"2023-08-18","current":-38.922819,"twenty":-48.618507,"median":-17.716316,"eighty":-1.669551,"marketCap":12898452069},{"date":"2023-08-25","current":-48.345542,"twenty":-48.469149,"median":-17.907229,"eighty":-1.691227,"marketCap":13869303300},{"date":"2023-09-01","current":-51.3714,"twenty":-48.848874,"median":-18.444474,"eighty":-1.700493,"marketCap":14798546621},{"date":"2023-09-08","current":-48.329437,"twenty":-48.855125,"median":-18.677203,"eighty":-1.704347,"marketCap":13758348873},{"date":"2023-09-15","current":-51.293354,"twenty":-49.02254,"median":-18.720104,"eighty":-1.706265,"marketCap":14715330801},{"date":"2023-09-22","current":-50.71226,"twenty":-49.227359,"median":-18.776742,"eighty":-1.712712,"marketCap":14485012880},{"date":"2023-09-29","current":-48.256147,"twenty":-49.384925,"median":-19.044047,"eighty":-1.719465,"marketCap":13807108743},{"date":"2023-10-06","current":-46.827986,"twenty":-49.333486,"median":-19.160007,"eighty":-1.722365,"marketCap":13392065394},{"date":"2023-10-13","current":-53.002537,"twenty":-49.510593,"median":-19.227015,"eighty":-1.723874,"marketCap":15135247460},{"date":"2023-10-20","current":-51.191925,"twenty":-49.7053,"median":-19.366357,"eighty":-1.725957,"marketCap":14595691106},{"date":"2023-10-27","current":-52.864392,"twenty":-49.863007,"median":-31.983773,"eighty":-1.729115,"marketCap":15066073568},{"date":"2023-11-03","current":-56.307135,"twenty":-50.091166,"median":-32.891609,"eighty":-1.731896,"marketCap":16089847162},{"date":"2023-11-10","current":-54.236606,"twenty":-50.200713,"median":-33.482197,"eighty":-1.734635,"marketCap":15494951696},{"date":"2023-11-17","current":-51.160216,"twenty":-50.265993,"median":-33.665831,"eighty":-1.738771,"marketCap":14747873667},{"date":"2023-11-24","current":-51.266082,"twenty":-50.347216,"median":-33.802098,"eighty":-1.742964,"marketCap":14900056229},{"date":"2023-12-01","current":-52.950552,"twenty":-50.44545,"median":-33.886683,"eighty":-1.749419,"marketCap":15453447361},{"date":"2023-12-08","current":-48.929335,"twenty":-50.480077,"median":-34.087991,"eighty":-1.750633,"marketCap":14222152092},{"date":"2023-12-15","current":-49.026997,"twenty":-50.503058,"median":-34.145914,"eighty":-1.755554,"marketCap":14332830318},{"date":"2023-12-22","current":-43.424521,"twenty":-50.480077,"median":-34.299503,"eighty":-1.767076,"marketCap":12686491701},{"date":"2023-12-29","current":-46.255966,"twenty":-50.462677,"median":-34.430704,"eighty":-1.768461,"marketCap":13585752290},{"date":"2024-01-05","current":-39.184116,"twenty":-50.422595,"median":-34.599164,"eighty":-1.773184,"marketCap":11427526875},{"date":"2024-01-12","current":-39.6374,"twenty":-50.376313,"median":-34.80723,"eighty":-1.779725,"marketCap":11565874658},{"date":"2024-01-19","current":-30.196245,"twenty":-50.355049,"median":-34.821291,"eighty":-1.786008,"marketCap":8798918998},{"date":"2024-01-26","current":-31.934796,"twenty":-50.349608,"median":-34.671634,"eighty":-1.788854,"marketCap":9269301461},{"date":"2024-02-02","current":-28.825732,"twenty":-50.344667,"median":-34.430704,"eighty":-1.792603,"marketCap":8356206093},{"date":"2024-02-09","current":-29.254358,"twenty":-50.300879,"median":-34.217523,"eighty":-1.798947,"marketCap":8522223432},{"date":"2024-02-16","current":-30.719933,"twenty":-50.268713,"median":-34.145914,"eighty":-1.80168,"marketCap":8951101560},{"date":"2024-02-23","current":-31.264593,"twenty":-50.247304,"median":-34.087991,"eighty":-1.80225,"marketCap":9061779786},{"date":"2024-03-01","current":-32.723882,"twenty":-50.231028,"median":-34.066835,"eighty":-1.804417,"marketCap":9490657913},{"date":"2024-03-08","current":-29.180924,"twenty":-50.209139,"median":-33.882824,"eighty":-1.810355,"marketCap":8466884319},{"date":"2024-03-15","current":-38.27424,"twenty":-50.205712,"median":-33.955792,"eighty":-1.815595,"marketCap":11095492196},{"date":"2024-03-22","current":-31.908479,"twenty":-50.190664,"median":-34.067344,"eighty":-1.818584,"marketCap":9241631904},{"date":"2024-03-28","current":-24.103932,"twenty":-50.165789,"median":-33.921238,"eighty":-1.822598,"marketCap":9379979687},{"date":"2024-04-05","current":-21.238245,"twenty":-50.161899,"median":-33.878964,"eighty":-1.824885,"marketCap":8259362645},{"date":"2024-04-12","current":-23.110595,"twenty":-50.151875,"median":-33.802098,"eighty":-1.826503,"marketCap":8992605895},{"date":"2024-04-19","current":-19.536242,"twenty":-50.114215,"median":-33.665831,"eighty":-1.826965,"marketCap":7595293286},{"date":"2024-04-26","current":-24.86909,"twenty":-50.088677,"median":-33.524232,"eighty":-1.828404,"marketCap":9656675253},{"date":"2024-05-03","current":-25.37705,"twenty":-50.062515,"median":-33.352238,"eighty":-1.831056,"marketCap":9847104749},{"date":"2024-05-10","current":-28.766023,"twenty":-49.984649,"median":-32.891609,"eighty":-1.83471,"marketCap":11188634469},{"date":"2024-05-17","current":-26.814161,"twenty":-49.910756,"median":-32.645746,"eighty":-1.838991,"marketCap":10414143084},{"date":"2024-05-24","current":-24.37715,"twenty":-49.863007,"median":-32.538199,"eighty":-1.85106,"marketCap":9446028853},{"date":"2024-05-31","current":-22.961819,"twenty":-49.832194,"median":-31.995691,"eighty":-1.851562,"marketCap":8906650925},{"date":"2024-06-07","current":-23.597218,"twenty":-49.791236,"median":-31.831896,"eighty":-1.853648,"marketCap":9141764381},{"date":"2024-06-14","current":-25.2268,"twenty":-49.715987,"median":-31.583979,"eighty":-1.855758,"marketCap":9764123529},{"date":"2024-06-21","current":-24.778424,"twenty":-49.68927,"median":-31.264593,"eighty":-1.85665,"marketCap":9570500683},{"date":"2024-06-28","current":-24.179737,"twenty":-49.630581,"median":-31.20565,"eighty":-1.861612,"marketCap":9335387227},{"date":"2024-07-05","current":-24.256649,"twenty":-49.579614,"median":-31.075409,"eighty":-1.863236,"marketCap":9363047634},{"date":"2024-07-12","current":-24.614617,"twenty":-49.543522,"median":-30.719933,"eighty":-1.864248,"marketCap":9515179870},{"date":"2024-07-19","current":-22.932666,"twenty":-49.516711,"median":-30.371914,"eighty":-1.866757,"marketCap":8865160315},{"date":"2024-07-26","current":-21.849753,"twenty":-49.509718,"median":-30.196245,"eighty":-1.877125,"marketCap":8477914622},{"date":"2024-08-02","current":-23.039429,"twenty":-49.464314,"median":-29.432845,"eighty":-1.879923,"marketCap":8934311331},{"date":"2024-08-09","current":-23.843465,"twenty":-49.442887,"median":-29.180924,"eighty":-1.895372,"marketCap":9307726820},{"date":"2024-08-16","current":-22.559268,"twenty":-49.415633,"median":-28.9562,"eighty":-1.89943,"marketCap":8809839502},{"date":"2024-08-23","current":-22.852245,"twenty":-49.399666,"median":-28.825732,"eighty":-1.901269,"marketCap":8961971738},{"date":"2024-08-30","current":-11.943567,"twenty":-49.3743,"median":-28.234141,"eighty":-1.902953,"marketCap":9750293326},{"date":"2024-09-06","current":-12.49661,"twenty":-49.298401,"median":-27.689087,"eighty":-1.905899,"marketCap":10206690035},{"date":"2024-09-13","current":-13.497126,"twenty":-49.241725,"median":-26.979872,"eighty":-1.909574,"marketCap":10995011623},{"date":"2024-09-20","current":-13.062266,"twenty":-49.227359,"median":-26.322214,"eighty":-1.921267,"marketCap":10704577354},{"date":"2024-09-27","current":-13.171028,"twenty":-49.207151,"median":-25.785602,"eighty":-1.928589,"marketCap":10858622900},{"date":"2024-10-04","current":-15.027739,"twenty":-49.149023,"median":-25.671471,"eighty":-1.933191,"marketCap":12333080578},{"date":"2024-10-10","current":-14.207383,"twenty":-49.070792,"median":-25.307724,"eighty":-1.941223,"marketCap":11588961750},{"date":"2024-10-18","current":-15.069052,"twenty":-49.03582,"median":-25.061172,"eighty":-1.946379,"marketCap":12222840752},{"date":"2024-10-25","current":-15.256895,"twenty":-49.024041,"median":-24.869468,"eighty":-1.949107,"marketCap":12374420513},{"date":"2024-11-01","current":-14.822157,"twenty":-49.000774,"median":-24.786784,"eighty":-1.954883,"marketCap":12029921055},{"date":"2024-11-08","current":-15.294589,"twenty":-48.949872,"median":-24.715433,"eighty":-1.968234,"marketCap":12319300600},{"date":"2024-11-15","current":-13.566563,"twenty":-48.916822,"median":-24.654219,"eighty":-1.969012,"marketCap":10844842922},{"date":"2024-11-22","current":-13.177664,"twenty":-48.864441,"median":-24.330876,"eighty":-1.969169,"marketCap":10527903421},{"date":"2024-11-29","current":-13.236939,"twenty":-48.855125,"median":-24.220233,"eighty":-1.969308,"marketCap":10569243356},{"date":"2024-12-06","current":-14.115834,"twenty":-48.853041,"median":-24.165087,"eighty":-1.969669,"marketCap":11244462292},{"date":"2024-12-13","current":-13.124464,"twenty":-48.843564,"median":-24.032421,"eighty":-1.970751,"marketCap":10445223551},{"date":"2024-12-20","current":-11.351432,"twenty":-48.816032,"median":-23.851379,"eighty":-1.972463,"marketCap":8984545851},{"date":"2024-12-27","current":-10.332247,"twenty":-48.747145,"median":-23.809649,"eighty":-1.97553,"marketCap":8171527131},{"date":"2025-01-03","current":-10.113262,"twenty":-48.716497,"median":-23.739142,"eighty":-1.990149,"marketCap":8006167392},{"date":"2025-01-10","current":-9.732379,"twenty":-48.613383,"median":-23.61918,"eighty":-2.006193,"marketCap":7675447913},{"date":"2025-01-17","current":-10.230835,"twenty":-48.469149,"median":-23.55525,"eighty":-2.01137,"marketCap":8075067283},{"date":"2025-01-24","current":-10.514129,"twenty":-48.405254,"median":-23.47864,"eighty":-2.012282,"marketCap":8350666849},{"date":"2025-01-28","current":-10.183162,"twenty":-48.397728,"median":-23.40795,"eighty":-2.012658,"marketCap":8130187197},{"date":"2025-02-07","current":-10.970133,"twenty":-48.362249,"median":-23.267866,"eighty":-2.014049,"marketCap":8708946285},{"date":"2025-02-14","current":-12.104222,"twenty":-48.345542,"median":-23.110595,"eighty":-2.015243,"marketCap":9604644875},{"date":"2025-02-21","current":-12.995643,"twenty":-48.329437,"median":-23.048952,"eighty":-2.019542,"marketCap":10348763703},{"date":"2025-02-28","current":-12.239978,"twenty":-48.256147,"median":-22.974507,"eighty":-2.021009,"marketCap":9714884701},{"date":"2025-03-07","current":-12.692506,"twenty":-48.245005,"median":-22.928973,"eighty":-2.025061,"marketCap":10114504072},{"date":"2025-03-14","current":-12.203883,"twenty":-48.229099,"median":-22.907908,"eighty":-2.084234,"marketCap":9728664679},{"date":"2025-03-21","current":-13.211656,"twenty":-48.147823,"median":-22.839239,"eighty":-2.088441,"marketCap":10527903421},{"date":"2025-03-28","current":-22.490798,"twenty":-48.083454,"median":-22.765665,"eighty":-2.095427,"marketCap":12401980470},{"date":"2025-04-03","current":-24.037662,"twenty":-47.928354,"median":-22.787126,"eighty":-2.100685,"marketCap":13228779168},{"date":"2025-04-11","current":-22.10626,"twenty":-47.790356,"median":-22.713245,"eighty":-2.109426,"marketCap":12085040969},{"date":"2025-04-17","current":-21.449842,"twenty":-47.728144,"median":-22.667693,"eighty":-2.112547,"marketCap":11754321489}],"updateTime":1745135044654}}}